Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Gene therapy vectors are rapidly approaching the commercial space so commercial readiness is critical for success. Watch our webinar to learn about our capabilities and approaches for preparing viral vectors for commercialization.